The Roche-backed antibody developer floated above its range and has seen its stock almost double in price.

The UCL and University of Houston spinout has raised more than $22m to date and is commercialising magnetic surgical guidance devices for breast cancer procedures.

Dongkoo Bio&Pharma and D&D Pharmatech both contributed to a series A round for the neurologic disorder drug spinout from Johns Hopkins.

The cardiac monitor developer has increased an Ascension Ventures-backed round to $35.4m, which will fund hiring and R&D.

Dongkoo Bio&Pharma and D&D Pharmatech both contributed to a series A round for the neurologic disorder drug developer.

The biologics production technology developer has secured $18.8m following a combined $6.8m from Takeda across 2015 and 2016.

Penn JPod will be one of two university-focused networking hubs backed by Johnson & Johnson to drive commercialisation and knowledge transfer in the healthcare sector.

UCL Technology Fund-backed gene therapy developer MeiraGTx has gone public on Nasdaq after raising $75m in proceeds in its initial public offering.